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Abstract
Background: Sebaceous carcinoma (SC) is a rare malignancy, occurring predominantly in eyelids. Till date, only 25
cases of sebaceous carcinoma (SC) of the parotid gland have been reported in world literature.
Case presentation: A 33 year-old male presented with left sided laterocervical mass. Clinical examination showed
enlargement of the left parotid gland, with cervical lymphadenopathy. No skin lesions were found. A resection of the
gland was performed. Pathological findings were consistent with primary sebaceous carcinoma of the parotid gland.
Conclusion: Sebaceous carcinoma of the parotid gland is extremely uncommon. Clinical and radiological features are
not specific. The aim of this report, is to describe histopathological, and immunohistochemical findings of this rare
entity, and discuss differential diagnosis.
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Background
Sebaceous glands are holocrine adnexal components of
the skin, usually found in close association with hair fol-
licles [1]. Sebaceous tumors are uncommon, and their
classification is controversial [2] Predominantly occurs
in eyelids [3], other sites may exceptionally be involved.
In the English literature, only 25 cases of sebaceous
carcinoma (SC) of the parotid gland have been reported
[4]. Sebaceous carcinoma is defined by the WHO as “a
malignant tumor composed of sebaceous cells of vary-
ing maturity that are arranged in sheets and/or nests
with different degrees of pleomorphism, nuclear aty-
pia, and invasiveness” [5]. Diagnosis may be difficult,
given the low incidence and inconsistencies in histo-
pathologic classification. Regardless of the location,
sebaceous carcinomas must be considered as an ag-
gressive neoplasm with a potential for regional and
distant metastasis [2].
We report an additional case, discuss the clinical and
pathologic features ; and briefly review of the literature,
Case presentation
A 33 year-old Moroccan male presented with left sided
laterocervical mass, which had persisted for four
months. No personal or family history was noted. He
had no previous history of smoking, alcohol use, or ir-
radiation. The mass had slowly grown with occasional
pain. He had no fever, chills, or weight loss. Upon phys-
ical examination, the left parotid gland was enlarged,
firm, with cervical lymphadenopathy, no skin lesions
were found. Ultrasonography and computed tomography
revealed a solid mass involving the parotid gland. A bi-
opsy revealed a poorly differentiated carcinoma.
The patient underwent tumor excision. The excised
mass measuring 21,5 × 9 × 6 cm, with skin tag measur-
ing 11 × 10 cm. The cut surface of the tumor was firm
tan-gray, lobulated, measuring 6 × 5,5 × 5 cm, with,
apparently normal looking, salivary gland tissue at the
peripheral margin (Fig. 1). Meticulous and extensive
sampling of the tumor was done.
Histopathological examination revealed a lobulated
tumor with expansive growth within parotid parenchyma
(Fig. 2). It was composed of nests of two cell populations
: large foamy cells with centrally located nuclei and
vacuolated clear cytoplasm, surrounded by closely
packed smaller basaloid cells with scanty cytoplasm
(Fig. 3). Large tumor cells showed sebaceous differenti-
ation (Fig. 4), with cellular pleomorphism, high mitotic
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activity (Fig. 5) and necrosis. Some areas showed squa-
mous islands with keratin pearl formation. Periodic
acid–Schiff (PAS) was negative in the foamy, large cells.
Immunohistochemical staining of the tumor showed
expression of epithelial membrane antigen (EMA)
(Fig. 6), pancytokeratin, and p63 in all neoplastic cells,
and focaly B-Catenin. They lacked expression of CK5/6,
CEA, S100, CD10, Vimentin, melan A, and CD45. The
diagnosis of Sebaceous carcinoma of the parotid gland
was made.
Since a recent literature review report a relation be-
tween sebaceous carcinoma and MSH2 mutation, we
evaluated by immunohistochemistry MLH1 and MSH2
protein expression. Strong nuclear expression of both
proteins was found (Figs. 7 and 8). All surgical margins
were microscopically negative. A staging computerised
tomography (CT), gastrointestinal endoscopy and colon-
oscopy were preformed and no tumor was found. Thus,
the Muir-Torre syndrome was excluded. Adjuvant radio-
therapy was decided. The patient is alive without signs
of tumor recurrence after 1 year of follow-up.
Discussion
Sebaceous carcinoma was first described in the salivary
glands by Rauch and Masshoff in [6]. It is a rare and aggres-
sive malignant neoplasm usually occurring in the head and
neck region [3], involving in 75 % the periocular region,
particularly the upper eyelid in elderly women [2]. Only
handful cases of primary salivary sebaceous carcinoma had
been described, most of them involving the parotid gland,
rarely the submandibular and minor salivary glands [7].
The histogenesis of sebaceous carcinoma in the par-
otid gland remain unclear. Sebaceous differentiation of
salivary ducts is seen in both normal and chronic siala-
denitis [3]. The parotid gland in the present case had
mild chronic inflammation. The current hypothesis is
that sebaceous carcinoma arises from pluripotent stem
cells, which can differentiate into sebaceous cells [7]. It
Fig. 1 Macroscopic aspects of the tumor after the en-block removal
Fig. 2 Low magnification of the tumor within to the parotid parenchyma
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is accepted that sebaceous lymphadenocarcinoma arises
from sebaceous lymphadenoma, but SC of the salivary
glands seems to be a de-novo lesion [2]. SC can be part
of Muir-Torre syndrome (MTS), and it was suggested
that expression of retinoid X receptor beta and gamma
could be related to the development of SC [8]. Muir-
Torre syndrome is a phenotypic variant of hereditary
non-polyposis colorectal cancer (HNPCC) or Lynch syn-
drome. Germline mutation in hMSH2 and hMLH1
genes are often associated with this disorder [9]. The
result for DNA mismatch repair genes in sporadic seba-
ceous carcinoma is inconclusive [3]. The most common
site for sebaceous neoplasms in Muir Torre Syndrome is
the eyelids and nose, and after extensive review of the
literature, the association between parotid sebaceous car-
cinoma in Muir Torre Syndrome has been reported only
once. In this present case, no association with Muir-
Torre syndrome was established, and immunohisto-
chemical staining showed normal nuclear expression of
MLH1 and MSH2 in tumor cells.
SC in the parotid gland is reported to occur in both
genders with the same incidence, and may have an in-
creased frequency in the asian population [2]. This
tumor has a bimodal age distribution, with a peak in the
second decade and another one in the seventh decade of
life (with a range of 6–92 years) [4].
Fig. 3 The tumor lobules composed of large foamy cells surrounded by basaloid cells
Fig. 4 numerous cells with sebaceous differentiation
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Clinically, the duration of symptoms is highly vari-
able and ranges from few months to 20 years. SC typ-
ically present as slowgrowing swellings with variable
pain, facial nerve involvement, and fixation to the
overlying skin. Rare cases have arisen from a preexist-
ing pleomorphic adenoma [10]. Our patient has no
history of an untreated or recurrent pleomorphic ad-
enoma ; also an extensive sampling of the tumor was
done, and no area of residual benign mixed tumour,
was found.
Grossly, tumors range in size from 0.6 to 8.5 cm, fre-
quently appear to be well circumscribed or partially en-
capsulated [5], gray to tan on the cut surface [11].
Microscopically, the tumor consists of sheets, nests, or
cords with expansive growth. Duct-like structures may
be numerous and cystic spaces of varying sizes are occa-
sionally present. The tumor may exhibit, pleomorphic
cells with variable degrees of cytologic atypia [11]. In
well-differentiated tumors, the cells have hyperchromatic
nuclei and abundant, cytoplasmic foamy vacuolization,
Fig. 5 Tumor cells showing nuclear atypia and mitosis
Fig. 6 Immunohistochemistry shows positive staining for EMA
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giving a typical sebaceous appearance [5]. Typically, se-
baceous neoplasic cells are located in the central parts of
the nests, which peripherally show more undifferentiated
cells with scarcer cytoplasm. A transition is observed be-
tween sebaceous and undifferentiated cells [12]. Squa-
mous differentiation in sebaceous neoplasms is common
[3]. Scattered mucous cells, xanthogranulomatous reac-
tion and oncocytic metaplasia are occasional findings
[11]. A positive lipid stain, such as oil-red-O or Sudan
IV, is helpful for establishing the diagnosis [1], but in
most cases not possible because frozen sections are not
always available [3].
Immunohistochemically, Androgen receptor (AR) is
useful in the diagnosis of poorly differentiated sebaceous
carcinomas [3], but there are no studies of AR in SC of
the salivary glands [2]. On the contrary, SC of the breast
is known to be positive for AR, indicating that ex-
pression of this receptor may be related to the site of
tumor origin [2]. EMA and HMFG1 (human milk fat
globule1) are expressed mainly by the sebaceous cells
both in the cytoplasm and membrane, but are nega-
tive in most of the basaloid peripheral cells [2]. Sev-
eral case reports and case series have confirmed the
usefulness of immunohistochemistry in diagnosing SC
[4]. But since most reported cases have no extensive
information on this issue, further studies are needed
to determine the most useful immunohistochemistry
panel in the diagnosis of SC.
Fig. 7 Immunohistochemistry shows positive staining for MSH2 in tumor cells and lymphocytes
Fig. 8 Immunohistochemistry shows positive staining for MLH1 in tumor cells
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Sebaceous carcinoma must be distinguished from
mucoepidemoid carcinoma, poorly differentiated squa-
mous carcinoma, basal cell carcinoma, and metastatic
clear cell renal carcinoma [4].
Unlike mucoepidemoid carcinoma, PAS and D-PAS in
SC stains negative. Malignant squamous cells may accu-
mulate glycogen and demonstrate clear cytoplasm.
Which can be confirmed by PAS staining, and positivity
of CK5/6 on immunohistochemistry.
The lack of lymphoid tissue did not support a diagno-
sis of sebaceous lymphadenocarcinoma [9].
Sebaceous Epithelial-Myoepithelial Carcinoma (EMC)
must be considered as a differential diagnosis. This
tumor is composed by bilayered ductal structures com-
posed of inner epithelial-type cells and outer myoepithe-
lial cells with clear cytoplasmic. The key feature to
distinguish sebaceous EMC from sebaceous carcinoma is
to reveal the myoepithelial nature of the tumor cells.
Mostly by using myoepithelial markers, such as calponin,
a-SMA, MSA, p63, CK 14, S-100 protein, and vimentin,
on immunohistochemistry [13].
The treatment of choice is wide surgical excision. Par-
otidectomy, extended parotidectomy, and/or neck dis-
section maybe required to achieve complete resection
[4]. Postoperative radiotherapy and chemotherapy, in tu-
mors with a high microscopic grade or clinical stage, has
occasionally been proposed [5, 9]. Out of reported cases,
9 were treated with radiotherapy. Although most re-
ported cases have no information on the tumor pro-
gression only 1 case treated with radiotherapy recurred
[4]. This indicates the beneficial role of radiotherapy as
treatment option in SC of the parotid. Our patient has
no signs of tumor recurrence after 1 year after adjuvant
radiotherapy. Metastasis may occur in the lung, brain,
and regional lymph nodes [4].
There are too few reported cases to make accurate
prognostic statements. Although extraocular cases were
considered less aggressive, this is no longer accepted [2].
At least 6 cases of SC of the salivary glands have been
described with recurrence and metastasis [12].
Conclusion
In summary, primary sebaceous carcinoma of the saliv-
ary glands is extremely rare and aggressive tumor, and
because of its rarity, clinicopathological characteristics
and histogenesis are not fully understood.
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